The FDA has announced new guidelines to ensure the safety and effectiveness of the COVID-19 vaccine in high-risk populations. This decision aligns with the CDC's recommendation to prioritize these vulnerable groups in the distribution of the vaccine.
The recent FDA panel on the safety of using SSRIs during pregnancy has sparked concern and debate among medical professionals and patients.
The FDA is questioning the safety and effectiveness of receiving multiple respiratory vaccines together, causing concern and raising doubts about the practice.
FDA tightens vaccine approval rules, emphasizing real clinical outcomes and expanded trials before market authorization.
The FDA has recommended the removal of the voluntary hold for Elevidys, a revolutionary medication for ambulatory patients.
Vinay Prasad, top FDA regulator, is reinstated after being ousted due to political tension and the need for regulatory independence.
The FDA's decision to prioritize high-risk individuals in approving new coronavirus vaccines reflects the urgent need to protect the most vulnerable and minimize the spread of the virus.
FDA warns about faulty Abbott FreeStyle Libre 3 sensors linked to deaths and injuries; replacement devices available.
The FDA has announced a crackdown on the opioid-like substance kratom, raising concerns about its potential for abuse and addiction. This blog explores the impact of the crackdown and the potential benefits for public health.
The Trump administration's FDA approval of a generic abortion drug sparks backlash amid debates over medication abortion and political influence.
GOP senators press the FDA on the abortion pill safety review after a closed-door briefing.
A memo from Vinay Prasad proposes stricter premarket trials for vaccines, sparking debate on safety, timelines, and access.
Massive recall of atorvastatin due to dissolution failures raises FDA oversight and global supply chain concerns.
FDA official Vinay Prasad faces scrutiny over a memo linking COVID-19 vaccines to pediatric deaths without supporting data.
The FDA approves Wegovy as the first oral GLP-1 therapy for long-term weight management and cardiovascular risk reduction.
FDA tightens vaccine rules for children amid safety concerns, prompting shared decision-making between parents and clinicians.
Trump's endorsement of leucovorin for autism sparks debate over CFD treatment and the need for larger trials.
FDA approves a generic mifepristone to ensure continued access to abortion medication amid a potential government shutdown.
The FDA has issued narrower approvals for Covid boosters, impacting their availability for children and adults who received a different brand of vaccine.
Apple Inc. has received FDA clearance for their smart watch to detect hypertension, paving the way for personalized and efficient healthcare.
